Literature DB >> 15007391

Multicenter linkage study of schizophrenia loci on chromosome 22q.

B J Mowry1, P A Holmans, A E Pulver, P V Gejman, B Riley, N M Williams, C Laurent, S G Schwab, D B Wildenauer, S Bauché, M J Owen, B Wormley, A R Sanders, G Nestadt, K Y Liang, J Duan, R Ribble, N Norton, S Soubigou, W Maier, K R Ewen-White, N DeMarchi, B Carpenter, D Walsh, H Williams, M Jay, M Albus, D A Nertney, G Papadimitriou, A O'Neill, M C O'Donovan, J-F Deleuze, F B Lerer, D Dikeos, K S Kendler, J Mallet, J M Silverman, R R Crowe, D F Levinson.   

Abstract

The hypothesis of the existence of one or more schizophrenia susceptibility loci on chromosome 22q is supported by reports of genetic linkage and association, meta-analyses of linkage, and the observation of elevated risk for psychosis in people with velocardiofacial syndrome, caused by 22q11 microdeletions. We tested this hypothesis by evaluating 10 microsatellite markers spanning 22q in a multicenter sample of 779 pedigrees. We also incorporated age at onset and sex into the analysis as covariates. No significant evidence for linkage to schizophrenia or for linkage associated with earlier age at onset, gender, or heterogeneity across sites was observed. We interpret these findings to mean that the population-wide effects of putative 22q schizophrenia susceptibility loci are too weak to detect with linkage analysis even in large samples.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15007391     DOI: 10.1038/sj.mp.4001481

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  15 in total

1.  A 200-kb region of human chromosome 22q11.2 confers antipsychotic-responsive behavioral abnormalities in mice.

Authors:  Noboru Hiroi; Hongwen Zhu; Moonsook Lee; Birgit Funke; Makoto Arai; Masanari Itokawa; Raju Kucherlapati; Bernice Morrow; Takehito Sawamura; Soh Agatsuma
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-19       Impact factor: 11.205

2.  Brain-specific disruption of the eIF2α kinase PERK decreases ATF4 expression and impairs behavioral flexibility.

Authors:  Mimi A Trinh; Hanoch Kaphzan; Ronald C Wek; Philippe Pierre; Douglas R Cavener; Eric Klann
Journal:  Cell Rep       Date:  2012-05-24       Impact factor: 9.423

Review 3.  Genetic models of schizophrenia and bipolar disorder: overlapping inheritance or discrete genotypes?

Authors:  Wolfgang Maier; Barbara Höfgen; Astrid Zobel; Marcella Rietschel
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2005-06       Impact factor: 5.270

4.  De novo mutations in the gene encoding the synaptic scaffolding protein SHANK3 in patients ascertained for schizophrenia.

Authors:  Julie Gauthier; Nathalie Champagne; Ronald G Lafrenière; Lan Xiong; Dan Spiegelman; Edna Brustein; Mathieu Lapointe; Huashan Peng; Mélanie Côté; Anne Noreau; Fadi F Hamdan; Anjené M Addington; Judith L Rapoport; Lynn E Delisi; Marie-Odile Krebs; Ridha Joober; Ferid Fathalli; Fayçal Mouaffak; Ali P Haghighi; Christian Néri; Marie-Pierre Dubé; Mark E Samuels; Claude Marineau; Eric A Stone; Philip Awadalla; Philip A Barker; Salvatore Carbonetto; Pierre Drapeau; Guy A Rouleau
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-12       Impact factor: 11.205

5.  Vitamin D deficiency, behavioral atypicality, anxiety and depression in children with chromosome 22q11.2 deletion syndrome.

Authors:  L Kelley; A F P Sanders; E A Beaton
Journal:  J Dev Orig Health Dis       Date:  2016-12       Impact factor: 2.401

6.  The importance of modelling heterogeneity in complex disease: application to NIMH Schizophrenia Genetics Initiative data.

Authors:  Elizabeth Holliday; Bryan Mowry; David Chant; Dale Nyholt
Journal:  Hum Genet       Date:  2005-04-21       Impact factor: 4.132

Review 7.  Analyses of the associations between the genes of 22q11 deletion syndrome and schizophrenia.

Authors:  Tadao Arinami
Journal:  J Hum Genet       Date:  2006-09-13       Impact factor: 3.172

8.  Genomewide high-density SNP linkage analysis of 236 Japanese families supports the existence of schizophrenia susceptibility loci on chromosomes 1p, 14q, and 20p.

Authors:  Tadao Arinami; Tsuyuka Ohtsuki; Hiroki Ishiguro; Hiroshi Ujike; Yuji Tanaka; Yukitaka Morita; Mari Mineta; Masashi Takeichi; Shigeto Yamada; Akira Imamura; Koichi Ohara; Haruo Shibuya; Kenshiro Ohara; Yasuo Suzuki; Tatsuyuki Muratake; Naoshi Kaneko; Toshiyuki Someya; Toshiya Inada; Takeo Yoshikawa; Tomoko Toyota; Kazuo Yamada; Takuya Kojima; Sakae Takahashi; Ohmori Osamu; Takahiro Shinkai; Michiko Nakamura; Hiroshi Fukuzako; Tomo Hashiguchi; Shin-ich Niwa; Takuya Ueno; Hirokazu Tachikawa; Takafumi Hori; Takashi Asada; Shinichiro Nanko; Hiroshi Kunugi; Ryota Hashimoto; Norio Ozaki; Nakao Iwata; Mutsuo Harano; Heii Arai; Tohru Ohnuma; Ichiro Kusumi; Tsukasa Koyama; Hiroshi Yoneda; Yasuyuki Fukumaki; Hiroki Shibata; Sunao Kaneko; Hisashi Higuchi; Norio Yasui-Furukori; Yohtaro Numachi; Masanari Itokawa; Yuji Okazaki
Journal:  Am J Hum Genet       Date:  2005-10-12       Impact factor: 11.025

9.  Genome-wide association study of multiplex schizophrenia pedigrees.

Authors:  Douglas F Levinson; Jianxin Shi; Kai Wang; Sang Oh; Brien Riley; Ann E Pulver; Dieter B Wildenauer; Claudine Laurent; Bryan J Mowry; Pablo V Gejman; Michael J Owen; Kenneth S Kendler; Gerald Nestadt; Sibylle G Schwab; Jacques Mallet; Deborah Nertney; Alan R Sanders; Nigel M Williams; Brandon Wormley; Virginia K Lasseter; Margot Albus; Stephanie Godard-Bauché; Madeline Alexander; Jubao Duan; Michael C O'Donovan; Dermot Walsh; Anthony O'Neill; George N Papadimitriou; Dimitris Dikeos; Wolfgang Maier; Bernard Lerer; Dominique Campion; David Cohen; Maurice Jay; Ayman Fanous; Peter Eichhammer; Jeremy M Silverman; Nadine Norton; Nancy Zhang; Hakon Hakonarson; Cynthia Gao; Ami Citri; Mark Hansen; Stephan Ripke; Frank Dudbridge; Peter A Holmans
Journal:  Am J Psychiatry       Date:  2012-09       Impact factor: 18.112

10.  Genomewide linkage scan of schizophrenia in a large multicenter pedigree sample using single nucleotide polymorphisms.

Authors:  P A Holmans; B Riley; A E Pulver; M J Owen; D B Wildenauer; P V Gejman; B J Mowry; C Laurent; K S Kendler; G Nestadt; N M Williams; S G Schwab; A R Sanders; D Nertney; J Mallet; B Wormley; V K Lasseter; M C O'Donovan; J Duan; M Albus; M Alexander; S Godard; R Ribble; K Y Liang; N Norton; W Maier; G Papadimitriou; D Walsh; M Jay; A O'Neill; F B Lerer; D Dikeos; R R Crowe; J M Silverman; D F Levinson
Journal:  Mol Psychiatry       Date:  2009-02-17       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.